COVAX allocates 4.7 mln AstraZeneca COVID-19 vaccine doses to N.Korea

The global vaccine-sharing network COVAX has set aside 4.73 million doses of AstraZeneca Plc's COVID-19 shot for shipment to North Korea, one of the very few countries that haven't started vaccination, according to its allocation plan. The plan follows an earlier offer for nearly two million doses of the shot that the reclusive state had rejected due to concerns over side effects, according to a South Korean think-tank